Login

C Moreau

ORCID: 0000-0002-0201-3062
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5036985579
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Liver Diseases and Immunity
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lung Cancer Treatments and Mutations
  • Neurological disorders and treatments
  • Machine Learning in Healthcare
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Statistical Methods and Inference
  • Hepatitis B Virus Studies
  • Pancreatitis Pathology and Treatment
  • Blood groups and transfusion
  • Immunodeficiency and Autoimmune Disorders
  • Eosinophilic Disorders and Syndromes
  • Pediatric health and respiratory diseases
  • Genetic and Kidney Cyst Diseases
  • Neonatal Respiratory Health Research
  • Parkinson's Disease Mechanisms and Treatments
  • Hepatitis C virus research
  • Congenital Anomalies and Fetal Surgery
  • Parathyroid Disorders and Treatments
  • Xenotransplantation and immune response
  • Pediatric Hepatobiliary Diseases and Treatments
  • Sarcoidosis and Beryllium Toxicity Research
  • Genetic Neurodegenerative Diseases

Université d'Angers
 2020-2023

Royal Cornwall Hospital
 1983

 Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
OPENALEX - Publications 
Jérôme Boursier Hannes Hagström Mattias Ekstedt C Moreau Martín Bonacci and 13 more S. Cure Javier Ampuero Patrik Nasr Lilian Tallab Clémence M. Canivet Stergios Kechagias Yolanda Sánchez Eloise Dincuff Ana Lucena Marine Roux Jérémie Riou Aldo Trylesinski Manuel Romero‐Gómez

10.1016/j.jhep.2021.12.031 article EN publisher-specific-oa Journal of Hepatology 2022-01-19
 Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trials
OPENALEX - Publications 
Jeanne Fichez Thomas Mouillot Luisa Vonghia Charlotte Costentin C Moreau and 5 more Marine Roux Adèle Delamarre Sven Francque Ming‐Hua Zheng Jérôme Boursier

10.1016/j.jhepr.2025.101351 article EN cc-by JHEP Reports 2025-02-01
 Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients
OPENALEX - Publications 
C Moreau Marine Roux Jérémie Riou Clémence M. Canivet Étienne Audureau and 4 more Clovis Lusivika‐Nzinga Pierre Nahon Fabrice Carrat Jérôme Boursier

Abstract Sustained viral response (SVR) significantly improves the prognosis in patients with hepatitis C virus (HCV) chronic infection but does not totally alleviate risk of liver‐related complications (LRC). We aimed to evaluate whether dynamics multiple measurements simple parameters after SVR enable development a personalized prediction HCV patients. mono‐infected who experienced two prospective cohorts (ANRS CO12 CirVir cohort: derivation set; ANRS CO22 HEPATHER validation set) were...

10.1111/jvh.13830 article EN Journal of Viral Hepatitis 2023-03-09
 OS-053 Screening candidates for therapeutic trials in MASH: choose the right non-invasive test for the diagnostic target considered
OPENALEX - Publications 
Jérôme Boursier Luisa Vonghia Charlotte Costentin Jeanne Fichez C Moreau and 5 more Marine Roux Clémence M. Canivet Victor de Lédinghen Sven Francque Ming‐Hua Zheng

10.1016/s0168-8278(24)00494-x article EN Journal of Hepatology 2024-06-01
 Étude prospective de la rythmicité chez 30 patients parkinsoniens débutants
OPENALEX - Publications 
M. Rambour C Moreau Céline Tard S. Bleuse Luc Defebvre and 1 more Arnaud Delval

10.1016/j.neucli.2014.09.018 article FR Neurophysiologie Clinique 2014-10-31
 Étude de l’impact de la progression de la fibrose hépatique chez les patients atteints de « non-alcoholic fatty liver disease »
OPENALEX - Publications 
C Moreau Jérôme Boursier Jérémie Riou Marine Roux

10.1016/j.respe.2020.03.083 article FR Revue d Épidémiologie et de Santé Publique 2020-09-01
Coming Soon ...